-
1
-
-
77952482571
-
Technosphere insulin: An inhaled prandial insulin product
-
Neumiller JJ, Campbell RK. Technosphere insulin: an inhaled prandial insulin product. BioDrugs 2010; 24: 165-172.
-
(2010)
BioDrugs
, vol.24
, pp. 165-172
-
-
Neumiller, J.J.1
Campbell, R.K.2
-
2
-
-
79951577062
-
Influence of particle size on regional lung deposition - What evidence is there?
-
Carvalho TC, Peters JI, Williams RO 3rd. Influence of particle size on regional lung deposition - what evidence is there? Int J Pharm 2011; 406: 1-10.
-
(2011)
Int J Pharm
, vol.406
, pp. 1-10
-
-
Carvalho, T.C.1
Peters, J.I.2
Williams III, R.O.3
-
3
-
-
67649970063
-
Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases
-
Smola M, Vandamme T, Sokolowski A. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int J Nanomed 2008; 3: 1-19.
-
(2008)
Int J Nanomed
, vol.3
, pp. 1-19
-
-
Smola, M.1
Vandamme, T.2
Sokolowski, A.3
-
5
-
-
33847127477
-
Particle engineering for pulmonary drug delivery
-
Chow AH, Tong HH, Chattopadhyay P, et al. Particle engineering for pulmonary drug delivery. Pharm Res 2007; 24: 411-437.
-
(2007)
Pharm Res
, vol.24
, pp. 411-437
-
-
Chow, A.H.1
Tong, H.H.2
Chattopadhyay, P.3
-
6
-
-
59649084577
-
Nano-salbutamol dry powder inhalation: A new approach for treating bronchoconstrictive conditions
-
Bhavna, Ahmad FJ, Mittal G, et al. Nano-salbutamol dry powder inhalation: a new approach for treating bronchoconstrictive conditions. Eur J Pharm Biopharm 2009; 71: 282-291.
-
(2009)
Eur J Pharm Biopharm
, vol.71
, pp. 282-291
-
-
Bhavna Ahmad, F.J.1
Mittal, G.2
-
8
-
-
84874897667
-
Therapeutic nanoparticles in clinics and under clinical evaluation
-
Schutz CA, Juillerat-Jeanneret L, Mueller H, et al. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomed (Lond) 2013; 8: 449-467.
-
(2013)
Nanomed (Lond)
, vol.8
, pp. 449-467
-
-
Schutz, C.A.1
Juillerat-Jeanneret, L.2
Mueller, H.3
-
9
-
-
49749133167
-
Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles
-
Wernig K, Griesbacher M, Andreae F, et al. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release 2008; 130: 192-198.
-
(2008)
J Control Release
, vol.130
, pp. 192-198
-
-
Wernig, K.1
Griesbacher, M.2
Andreae, F.3
-
10
-
-
79951950063
-
Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model
-
Oh YJ, Lee J, Seo JY, et al. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model. J Control Release 2011; 150: 56-62.
-
(2011)
J Control Release
, vol.150
, pp. 56-62
-
-
Oh, Y.J.1
Lee, J.2
Seo, J.Y.3
-
11
-
-
25144447412
-
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis
-
Ahmad Z, Sharma S, Khuller GK. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 2005; 26: 298-303.
-
(2005)
Int J Antimicrob Agents
, vol.26
, pp. 298-303
-
-
Ahmad, Z.1
Sharma, S.2
Khuller, G.K.3
-
12
-
-
33745904988
-
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
-
Azarmi S, Tao X, Chen H, et al. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm 2006; 319: 155-161.
-
(2006)
Int J Pharm
, vol.319
, pp. 155-161
-
-
Azarmi, S.1
Tao, X.2
Chen, H.3
-
13
-
-
84890452320
-
Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: Efficacy and biofate in a lung cancer mouse model
-
Karra N, Nassar T, Ripin AN, et al. Antibody conjugated PLGA nanoparticles for targeted delivery of paclitaxel palmitate: efficacy and biofate in a lung cancer mouse model. Small 2013; 9: 4221-4236.
-
(2013)
Small
, vol.9
, pp. 4221-4236
-
-
Karra, N.1
Nassar, T.2
Ripin, A.N.3
-
14
-
-
42349094203
-
Nanoparticles in medicine: Therapeutic applications and developments
-
Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2008; 83: 761-769.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 761-769
-
-
Zhang, L.1
Gu, F.X.2
Chan, J.M.3
-
15
-
-
0038032150
-
Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of the art
-
Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161-177.
-
(2000)
Eur J Pharm Biopharm
, vol.50
, pp. 161-177
-
-
Muller, R.H.1
Mader, K.2
Gohla, S.3
-
16
-
-
81355147743
-
Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery
-
Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliver Rev 2011; 63: 1247-1256.
-
(2011)
Adv Drug Deliver Rev
, vol.63
, pp. 1247-1256
-
-
Yoo, J.W.1
Doshi, N.2
Mitragotri, S.3
-
17
-
-
84857119766
-
Recent advances in stealth coating of nanoparticle drug delivery systems
-
Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012; 4: 219-233.
-
(2012)
Wiley Interdiscip Rev Nanomed Nanobiotechnol
, vol.4
, pp. 219-233
-
-
Amoozgar, Z.1
Yeo, Y.2
-
18
-
-
84877267457
-
Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles
-
Yuan H, Chen CY, Chai GH, et al. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. Mol Pharm 2013; 10: 1865-1873.
-
(2013)
Mol Pharm
, vol.10
, pp. 1865-1873
-
-
Yuan, H.1
Chen, C.Y.2
Chai, G.H.3
-
19
-
-
84870720550
-
Application of polysaccharides for surface modification of nanomedicines
-
Doh KO, Yeo Y. Application of polysaccharides for surface modification of nanomedicines. Ther Deliv 2012; 3: 1447-1456.
-
(2012)
Ther Deliv
, vol.3
, pp. 1447-1456
-
-
Doh, K.O.1
Yeo, Y.2
-
20
-
-
84873853768
-
Biomolecular coronas provide the biological identity of nanosized materials
-
Monopoli MP, Aberg C, Salvati A, et al. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012; 7: 779-786.
-
(2012)
Nat Nanotechnol
, vol.7
, pp. 779-786
-
-
Monopoli, M.P.1
Aberg, C.2
Salvati, A.3
-
21
-
-
84863678205
-
The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles
-
Ruge CA, Schaefer UF, Herrmann J, et al. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLos One 2012; 7: e40775.
-
(2012)
PLos One
, vol.7
-
-
Ruge, C.A.1
Schaefer, U.F.2
Herrmann, J.3
-
22
-
-
82255191648
-
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A
-
Ruge CA, Kirch J, Canadas O, et al. Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 2011; 7: 690-693.
-
(2011)
Nanomedicine
, vol.7
, pp. 690-693
-
-
Ruge, C.A.1
Kirch, J.2
Canadas, O.3
-
23
-
-
70350653772
-
Interaction of nanoparticles with the pulmonary surfactant system
-
Schleh C, Hohlfeld JM. Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol 2009; 21: Suppl. 1, 97-103.
-
(2009)
Inhal Toxicol
, vol.21
, Issue.SUPPL. 1
, pp. 97-103
-
-
Schleh, C.1
Hohlfeld, J.M.2
-
24
-
-
84880081982
-
Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles
-
Kendall M, Ding P, Mackay RM, et al. Surfactant protein D (SP-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 2013; 7: 963-973.
-
(2013)
Nanotoxicology
, vol.7
, pp. 963-973
-
-
Kendall, M.1
Ding, P.2
Mackay, R.M.3
-
25
-
-
78049455169
-
Interaction of soot derived multi-carbon nanoparticles with lung surfactants and their possible internalization inside alveolar cavity
-
Kumar P, Bohidar HB. Interaction of soot derived multi-carbon nanoparticles with lung surfactants and their possible internalization inside alveolar cavity. Indian J Exp Biol 2010; 48: 1037-1042.
-
(2010)
Indian J Exp Biol
, vol.48
, pp. 1037-1042
-
-
Kumar, P.1
Bohidar, H.B.2
-
26
-
-
77957894948
-
Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies
-
Wang L, Castranova V, Mishra A, et al. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 2010; 7: 31.
-
(2010)
Part Fibre Toxicol
, vol.7
, pp. 31
-
-
Wang, L.1
Castranova, V.2
Mishra, A.3
-
27
-
-
0033839080
-
Openings between defective endothelial cells explain tumor vessel leakiness
-
Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156: 1363-1380.
-
(2000)
Am J Pathol
, vol.156
, pp. 1363-1380
-
-
Hashizume, H.1
Baluk, P.2
Morikawa, S.3
-
28
-
-
84859487837
-
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis
-
Fasol U, Frost A, Buchert M, et al. Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. Ann Oncol 2012; 23: 1030-1036.
-
(2012)
Ann Oncol
, vol.23
, pp. 1030-1036
-
-
Fasol, U.1
Frost, A.2
Buchert, M.3
-
29
-
-
34147102301
-
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages
-
Hirota K, Hasegawa T, Hinata H, et al. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages. J Control Release 2007; 119: 69-76.
-
(2007)
J Control Release
, vol.119
, pp. 69-76
-
-
Hirota, K.1
Hasegawa, T.2
Hinata, H.3
-
31
-
-
0141990623
-
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
-
Schiffelers RM, Koning GA, ten Hagen TL, et al. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003; 91: 115-122.
-
(2003)
J Control Release
, vol.91
, pp. 115-122
-
-
Schiffelers, R.M.1
Koning, G.A.2
Ten Hagen, T.L.3
-
32
-
-
74849112431
-
Synergistic targeting of αvβ3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis
-
Kluza E, van der Schaft DW, Hautvast PA, et al. Synergistic targeting of αvβ3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett 2010; 10: 52-58.
-
(2010)
Nano Lett
, vol.10
, pp. 52-58
-
-
Kluza, E.1
Van Der Schaft, D.W.2
Hautvast, P.A.3
-
33
-
-
70350207175
-
Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting
-
Chen K, Xie J, Xu H, et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009; 30: 6912-6919.
-
(2009)
Biomaterials
, vol.30
, pp. 6912-6919
-
-
Chen, K.1
Xie, J.2
Xu, H.3
-
34
-
-
84874591329
-
Receptor-based targeting of therapeutics
-
Mehra NK, Mishra V, Jain NK. Receptor-based targeting of therapeutics. Ther Deliv 2013; 4: 369-394.
-
(2013)
Ther Deliv
, vol.4
, pp. 369-394
-
-
Mehra, N.K.1
Mishra, V.2
Jain, N.K.3
-
35
-
-
0343882023
-
Targeted drug delivery via the folate receptor
-
Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000; 41: 147-162.
-
(2000)
Adv Drug Deliv Rev
, vol.41
, pp. 147-162
-
-
Sudimack, J.1
Lee, R.J.2
-
36
-
-
1842638560
-
Folate receptor targeted biodegradable polymeric doxorubicin micelles
-
Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004; 96: 273-283.
-
(2004)
J Control Release
, vol.96
, pp. 273-283
-
-
Yoo, H.S.1
Park, T.G.2
-
37
-
-
84857371220
-
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
-
Daniels TR, Bernabeu E, Rodriguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 2012; 1820: 291-317.
-
(2012)
Biochim Biophys Acta
, vol.1820
, pp. 291-317
-
-
Daniels, T.R.1
Bernabeu, E.2
Rodriguez, J.A.3
-
38
-
-
0036464722
-
Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells
-
Wiewrodt R, Thomas AP, Cipelletti L, et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood 2002; 99: 912-922.
-
(2002)
Blood
, vol.99
, pp. 912-922
-
-
Wiewrodt, R.1
Thomas, A.P.2
Cipelletti, L.3
-
39
-
-
33748673542
-
pH-responsive shielding of non-viral gene vectors
-
Meyer M, Wagner E. pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv 2006; 3: 563-571.
-
(2006)
Expert Opin Drug Deliv
, vol.3
, pp. 563-571
-
-
Meyer, M.1
Wagner, E.2
-
40
-
-
67249151969
-
Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate
-
Meyer M, Dohmen C, Philipp A, et al. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol Pharm 2009; 6: 752-762.
-
(2009)
Mol Pharm
, vol.6
, pp. 752-762
-
-
Meyer, M.1
Dohmen, C.2
Philipp, A.3
-
41
-
-
33845625261
-
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
-
Hatakeyama H, Akita H, Kogure K, et al. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 2007; 14: 68-77.
-
(2007)
Gene Ther
, vol.14
, pp. 68-77
-
-
Hatakeyama, H.1
Akita, H.2
Kogure, K.3
-
42
-
-
84870249845
-
Crucial factors and emerging concepts in ultrasound-triggered drug delivery
-
Geers B, Dewitte H, De Smedt SC, et al. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J Control Release 2012; 164: 248-255.
-
(2012)
J Control Release
, vol.164
, pp. 248-255
-
-
Geers, B.1
Dewitte, H.2
De Smedt, S.C.3
-
43
-
-
84883196945
-
Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery
-
Sirsi SR, Fung C, Garg S, et al. Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery. Theranostics 2013; 3: 409-419.
-
(2013)
Theranostics
, vol.3
, pp. 409-419
-
-
Sirsi, S.R.1
Fung, C.2
Garg, S.3
-
44
-
-
84862700846
-
Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung
-
Hasenpusch G, Geiger J, Wagner K, et al. Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung. Pharm Res 2012; 29: 1308-1318.
-
(2012)
Pharm Res
, vol.29
, pp. 1308-1318
-
-
Hasenpusch, G.1
Geiger, J.2
Wagner, K.3
-
45
-
-
84885190174
-
New perspectives in nanomedicine
-
Thorley AJ, Tetley TD. New perspectives in nanomedicine. Pharmacol Ther 2013; 140: 176-185.
-
(2013)
Pharmacol Ther
, vol.140
, pp. 176-185
-
-
Thorley, A.J.1
Tetley, T.D.2
-
47
-
-
84904750312
-
A concise review of carbon nanotube's toxicology
-
in press DOI: 10.3402/nano.v4i0.21521
-
Madani SY, Mandel A, Seifalian AM. A concise review of carbon nanotube's toxicology. Nano Rev 2013 (in press DOI: 10.3402/nano.v4i0.21521).
-
(2013)
Nano Rev
-
-
Madani, S.Y.1
Mandel, A.2
Seifalian, A.M.3
-
48
-
-
33644748178
-
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers
-
Singh R, Pantarotto D, Lacerda L, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci USA 2006; 103: 3357-3362.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3357-3362
-
-
Singh, R.1
Pantarotto, D.2
Lacerda, L.3
-
49
-
-
32944482677
-
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
-
Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 2005; 23: 7794-7803.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7794-7803
-
-
Gradishar, W.J.1
Tjulandin, S.2
Davidson, N.3
-
50
-
-
84865654435
-
A docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases
-
Ernsting MJ, Murakami M, Undzys E, et al. A docetaxel- carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastases. J Control Release 2012; 162: 575-581.
-
(2012)
J Control Release
, vol.162
, pp. 575-581
-
-
Ernsting, M.J.1
Murakami, M.2
Undzys, E.3
-
51
-
-
34247897230
-
Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung
-
Wittgen BP, Kunst PW, van der Born K, et al. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res 2007; 13: 2414-2421.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2414-2421
-
-
Wittgen, B.P.1
Kunst, P.W.2
Van Der Born, K.3
-
52
-
-
70349679107
-
Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases
-
Latimer P, Menchaca M, Snyder RM, et al. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med 2009; 234: 1244-1252.
-
(2009)
Exp Biol Med
, vol.234
, pp. 1244-1252
-
-
Latimer, P.1
Menchaca, M.2
Snyder, R.M.3
-
53
-
-
1842479077
-
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies
-
Verschraegen CF, Gilbert BE, Loyer E, et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 2004; 10: 2319-2326.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 2319-2326
-
-
Verschraegen, C.F.1
Gilbert, B.E.2
Loyer, E.3
-
54
-
-
77951011298
-
Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer
-
Otterson GA, Villalona-Calero MA, Hicks W, et al. Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin Cancer Res 2010; 16: 2466-2473.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 2466-2473
-
-
Otterson, G.A.1
Villalona-Calero, M.A.2
Hicks, W.3
-
55
-
-
46049096465
-
Molecular recognition of small-cell lung cancer cells using aptamers
-
Chen HW, Medley CD, Sefah K, et al. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 2008; 3: 991-1001.
-
(2008)
ChemMedChem
, vol.3
, pp. 991-1001
-
-
Chen, H.W.1
Medley, C.D.2
Sefah, K.3
-
56
-
-
70349326658
-
Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells
-
Zhao Z, Xu L, Shi X, et al. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst 2009; 134: 1808-1814.
-
(2009)
Analyst
, vol.134
, pp. 1808-1814
-
-
Zhao, Z.1
Xu, L.2
Shi, X.3
-
57
-
-
67349255031
-
The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation
-
Tseng CL, Su WY, Yen KC, et al. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009; 30: 3476-3485.
-
(2009)
Biomaterials
, vol.30
, pp. 3476-3485
-
-
Tseng, C.L.1
Su, W.Y.2
Yen, K.C.3
-
58
-
-
78650572411
-
Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice
-
Bhirde AA, Patel S, Sousa AA, et al. Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice. Nanomed (Lond) 2010; 5: 1535-1546.
-
(2010)
Nanomed (Lond)
, vol.5
, pp. 1535-1546
-
-
Bhirde, A.A.1
Patel, S.2
Sousa, A.A.3
-
59
-
-
33750417183
-
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
-
Li SD, Huang L. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm 2006; 3: 579-588.
-
(2006)
Mol Pharm
, vol.3
, pp. 579-588
-
-
Li, S.D.1
Huang, L.2
-
60
-
-
0035571761
-
Pulmonary disposition of budesonide from liposomal dry powder inhaler
-
Joshi M, Misra AN. Pulmonary disposition of budesonide from liposomal dry powder inhaler. Methods Find Exp Clin Pharmacol 2001; 23: 531-536.
-
(2001)
Methods Find Exp Clin Pharmacol
, vol.23
, pp. 531-536
-
-
Joshi, M.1
Misra, A.N.2
-
61
-
-
0036892679
-
Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids
-
Saari SM, Vidgren MT, Herrala J, et al. Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids. Resp Med 2002; 96: 999-1005.
-
(2002)
Resp Med
, vol.96
, pp. 999-1005
-
-
Saari, S.M.1
Vidgren, M.T.2
Herrala, J.3
-
62
-
-
0032924188
-
Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers
-
Saari M, Vidgren MT, Koskinen MO, et al. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharm 1999; 181: 1-9.
-
(1999)
Int J Pharm
, vol.181
, pp. 1-9
-
-
Saari, M.1
Vidgren, M.T.2
Koskinen, M.O.3
-
63
-
-
79952598362
-
Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine
-
Suk JS, Lai SK, Boylan NJ, et al. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomed (Lond) 2011; 6: 365-375.
-
(2011)
Nanomed (Lond)
, vol.6
, pp. 365-375
-
-
Suk, J.S.1
Lai, S.K.2
Boylan, N.J.3
-
64
-
-
47349122617
-
Biodegradable polymeric nanocarriers for pulmonary drug delivery
-
Rytting E, Nguyen J, Wang X, et al. Biodegradable polymeric nanocarriers for pulmonary drug delivery. Expert Opin Drug Deliv 2008; 5: 629-639.
-
(2008)
Expert Opin Drug Deliv
, vol.5
, pp. 629-639
-
-
Rytting, E.1
Nguyen, J.2
Wang, X.3
-
66
-
-
60149111908
-
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
-
Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliver Rev 2009; 61: 158-171.
-
(2009)
Adv Drug Deliver Rev
, vol.61
, pp. 158-171
-
-
Lai, S.K.1
Wang, Y.Y.2
Hanes, J.3
-
67
-
-
84878002619
-
Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease
-
Geiser M, Quaile O, Wenk A, et al. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 2013; 10: 19.
-
(2013)
Part Fibre Toxicol
, vol.10
, pp. 19
-
-
Geiser, M.1
Quaile, O.2
Wenk, A.3
-
68
-
-
70350393883
-
Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model
-
Matsuo Y, Ishihara T, Ishizaki J, et al. Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model. Cell Immunol 2009; 260: 33-38.
-
(2009)
Cell Immunol
, vol.260
, pp. 33-38
-
-
Matsuo, Y.1
Ishihara, T.2
Ishizaki, J.3
-
69
-
-
84861415187
-
Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: Physicochemical characterization and in vitro, in vivo evaluations
-
Sahib MN, Darwis Y, Peh KK, et al. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Int J Nanomedicine 2011; 6: 2351-2366.
-
(2011)
Int J Nanomedicine
, vol.6
, pp. 2351-2366
-
-
Sahib, M.N.1
Darwis, Y.2
Peh, K.K.3
-
70
-
-
0035979417
-
Dry powder inhalation of liposomal ketotifen fumarate: Formulation and characterization
-
Joshi M, Misra A. Dry powder inhalation of liposomal ketotifen fumarate: formulation and characterization. Int J Pharm 2001; 223: 15-27.
-
(2001)
Int J Pharm
, vol.223
, pp. 15-27
-
-
Joshi, M.1
Misra, A.2
-
71
-
-
0037344143
-
Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung
-
Joshi M, Misra A. Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung. Clin Exp Pharmacol Physiol 2003; 30: 153-156.
-
(2003)
Clin Exp Pharmacol Physiol
, vol.30
, pp. 153-156
-
-
Joshi, M.1
Misra, A.2
-
72
-
-
84872120268
-
Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans
-
Bruinenberg P, Serisier D, Cipolla D, et al. Safety, tolerability, pharmacokinetics and antimicrobial activity of inhaled liposomal ciprofloxacin formulations in humans. Pediatr Pulm 2010; 354-354.
-
(2010)
Pediatr Pulm
, pp. 354-354
-
-
Bruinenberg, P.1
Serisier, D.2
Cipolla, D.3
-
73
-
-
67549135653
-
A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers
-
Weers J, Metzheiser B, Taylor G, et al. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 2009; 22: 131-138.
-
(2009)
J Aerosol Med Pulm Drug Deliv
, vol.22
, pp. 131-138
-
-
Weers, J.1
Metzheiser, B.2
Taylor, G.3
-
74
-
-
70349084570
-
Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection
-
Okusanya OO, Bhavnani SM, Hammel J, et al. Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection. Antimicrob Agents Chemother 2009; 53: 3847-3854.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3847-3854
-
-
Okusanya, O.O.1
Bhavnani, S.M.2
Hammel, J.3
-
75
-
-
0028560407
-
Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis
-
Allen SD, Sorensen KN, Nejdl MJ, et al. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J Antimicrob Chemother 1994; 34: 1001-1013.
-
(1994)
J Antimicrob Chemother
, vol.34
, pp. 1001-1013
-
-
Allen, S.D.1
Sorensen, K.N.2
Nejdl, M.J.3
-
76
-
-
56949108347
-
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial
-
Slobbe L, Boersma E, Rijnders BJ. Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial. Pulm Pharmacol Ther 2008; 21: 855-859.
-
(2008)
Pulm Pharmacol Ther
, vol.21
, pp. 855-859
-
-
Slobbe, L.1
Boersma, E.2
Rijnders, B.J.3
-
77
-
-
77956930518
-
Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
-
Vij N, Min T, Marasigan R, et al. Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnology 2010; 8: 22.
-
(2010)
J Nanobiotechnology
, vol.8
, pp. 22
-
-
Vij, N.1
Min, T.2
Marasigan, R.3
-
78
-
-
33750010667
-
Gene therapy for cystic fibrosis lung disease: Current status and future perspectives
-
Rosenecker J, Huth S, Rudolph C. Gene therapy for cystic fibrosis lung disease: current status and future perspectives. Curr Opin Mol Ther 2006; 8: 439-445.
-
(2006)
Curr Opin Mol Ther
, vol.8
, pp. 439-445
-
-
Rosenecker, J.1
Huth, S.2
Rudolph, C.3
-
79
-
-
84869773544
-
Liposomal delivery of proteins and peptides
-
Swaminathan J, Ehrhardt C. Liposomal delivery of proteins and peptides. Expert Opin Drug Deliv 2012; 9: 1489-1503.
-
(2012)
Expert Opin Drug Deliv
, vol.9
, pp. 1489-1503
-
-
Swaminathan, J.1
Ehrhardt, C.2
-
80
-
-
33646343208
-
Increased intracellular targeting to airway cells using octaarginine-coated liposomes: In vitro assessment of their suitability for inhalation
-
Cryan SA, Devocelle M, Moran PJ, et al. Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation. Mol Pharm 2006; 3: 104-112.
-
(2006)
Mol Pharm
, vol.3
, pp. 104-112
-
-
Cryan, S.A.1
Devocelle, M.2
Moran, P.J.3
-
82
-
-
17144401470
-
Novel molecular approaches to cystic fibrosis gene therapy
-
Lee TW, Matthews DA, Blair GE. Novel molecular approaches to cystic fibrosis gene therapy. Biochem J 2005; 387: 1-15.
-
(2005)
Biochem J
, vol.387
, pp. 1-15
-
-
Lee, T.W.1
Matthews, D.A.2
Blair, G.E.3
-
83
-
-
0030759153
-
Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo
-
Zabner J, Cheng SH, Meeker D, et al. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 1997; 100: 1529-1537.
-
(1997)
J Clin Invest
, vol.100
, pp. 1529-1537
-
-
Zabner, J.1
Cheng, S.H.2
Meeker, D.3
-
84
-
-
0034193342
-
Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: Comparison with protein therapy
-
Brigham KL, Lane KB, Meyrick B, et al. Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy. Hum Gene Ther 2000; 11: 1023-1032.
-
(2000)
Hum Gene Ther
, vol.11
, pp. 1023-1032
-
-
Brigham, K.L.1
Lane, K.B.2
Meyrick, B.3
|